Neomorph News and Activities

Acquisition, funding and merger involving Neomorph.

• Neomorph has just announced a $100 Million fundraising (posted on April 15 2026).

View the org chart displaying its 22 main executives

Most searched biographies at Neomorph

• Philip Chamberlain, Chief Executive Officer and Director
• Eric Fischer, Director
• Joseph Pearlberg, Director

Popular executive movements at Neomorph

• Bob Hugin has joined the company as Chairman of the Board  (posted on May 14 2026).

Create your alert
to follow the executive moves at Neomorph.

Neomorph has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Neomorph

• Neomorph | News & Media
• Neomorph Announces Appointment of Dr. Klaus Wagner, M.D., Ph.D. as Chief Medical Officer
• Neomorph Announces Appointment of Dr. Peter Lebowitz, M.D., Ph.D. to its Board of Directors
• Neomorph, Inc. to Participate in Upcoming Guggenheim Healthcare Talks – Targeted Protein Degradation Day
• Neomorph, Inc. Announces $109 Million Series A Financing to Advance Proprietary Protein Degradation Platform and Programs
• Philip Chamberlain Named as Chief Executive Officer of Neomorph
• Home - Neomorph
• View more press releases Close

Social media about Neomorph

• Neomorph on Wikipedia, Google News & Yahoo Finance
• Neomorph on LinkedIn, X (Twitter) & YouTube